EIB funds Ebola vaccine development

Published: 20-Jan-2015
Research & Development Infection Control

Lends Bavarian Nordic €50m to accelerate Ebola project


The European Investment Bank (EIB) is lending €50m to Denmark-based biotechnology company Bavarian Nordic to accelerate its work in developing a vaccine against the Ebola virus. The decision showed that the bank backed 'investment where it is needed…in difficult or uncertain circumstances', claimed EIB President Werner Hoyer. The company started Phase 1 clinical trials this month.

See more

You may also like

Research & Development

EIB supports Bavarian Nordic’s development of Ebola and cancer vaccines

Read more
Prostvac is the company's leading targeted immunotherapy candidate

Trending Articles

  1. Thermo Fisher Scientific reveals MagMax Sequential DNA/RNA Kit to advance blood cancer research The kit combines DNA and RNA isolation chemistries into a single kit, simplifying sample extraction for a broad range of downstream molecular applications
  2. Lonza At Lonza, we enable a healthier world by supporting our healthcare customers on the path to commercialization. Our community of around 17,500 skilled employees work across a global network of more than 30 sites to deliver for our customers across the pharma, biotech and nutrition markets. <br> <br> By combining technological insight with world-class manufacturing, scientific expertise and process excellence, we help our customers to deliver new and innovative medicines that help treat a wide range of diseases.
  3. How iPSCs can bridge the translational gap in neuroscience Affecting more than one in three people, neurological disorders have a vast impact on global health while exacting a tremendous cost, reports Dr Max Mirza, Vice President of Neuroscience Drug Discovery at Sygnature Discovery
  4. New Sicco desiccators and drying cabinets guide available now Flexible and robust solutions for drying and storage
  5. Thermo Fisher Scientific officially opens US oral solid dose testing and R&D facility The company's further expansion in the Bend, Oregon area will assist its pharmaceutical clients in the early development of oral solid dosage (OSD) forms

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

You may also like

Research & Development

EIB supports Bavarian Nordic’s development of Ebola and cancer vaccines

Prostvac is the company's leading targeted immunotherapy candidate
Research & Development

Thermo Fisher Scientific reveals MagMax Sequential DNA/RNA Kit to advance blood cancer research

The kit combines DNA and RNA isolation chemistries into a single kit, simplifying sample extraction for a broad range of downstream molecular applications
Manufacturing

Precise and efficient VARIO diaphragm pumps from Vacuubrand

Advanced vacuum control for reproducible processes
Manufacturing

Isopod rapid cleanrooms helping life science start-ups and smaller businesses grow

The Guardtech Group’s quick-assembly pods provide a fast, high-quality cleanroom solution
Regulatory

Asahi Kasei Pharma grows its global portfolio with anti-CX3CR1 license

The licensing deal with Chiome enhances its open innovation platform
Sustainability

SPT Labtech integrates barcode scanner with elabnext platform

New tool boosts sample tracking and data integrity in life science labs
Manufacturing

Solvent recycler SPR-200 boosts sustainability in pharma labs

Recycling up to 90% of solvent in isocratic HPLC improves lab efficiency and sustainability
Subscribe now